FI901363A0 - Tetrahydronaftalinderivat. - Google Patents
Tetrahydronaftalinderivat.Info
- Publication number
- FI901363A0 FI901363A0 FI901363A FI901363A FI901363A0 FI 901363 A0 FI901363 A0 FI 901363A0 FI 901363 A FI901363 A FI 901363A FI 901363 A FI901363 A FI 901363A FI 901363 A0 FI901363 A0 FI 901363A0
- Authority
- FI
- Finland
- Prior art keywords
- tetrahydronaftalinderivat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/25—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/64—Acyl halides
- C07C57/76—Acyl halides containing halogen outside the carbonyl halide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/24—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/48—Halogenated derivatives
- C07C35/52—Alcohols with a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH107489 | 1989-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
FI901363A0 true FI901363A0 (fi) | 1990-03-19 |
Family
ID=4201845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI901363A FI901363A0 (fi) | 1989-03-20 | 1990-03-19 | Tetrahydronaftalinderivat. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5120759A (no) |
EP (1) | EP0388739A1 (no) |
JP (1) | JPH02279660A (no) |
KR (1) | KR900014306A (no) |
AU (1) | AU5140390A (no) |
CA (1) | CA2011461A1 (no) |
FI (1) | FI901363A0 (no) |
HU (1) | HUT58042A (no) |
IL (1) | IL93750A0 (no) |
MC (1) | MC2105A1 (no) |
NO (1) | NO901266L (no) |
PH (1) | PH26903A (no) |
PT (1) | PT93504A (no) |
YU (1) | YU53490A (no) |
ZA (1) | ZA901926B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5910606A (en) * | 1996-01-31 | 1999-06-08 | Hoffmann-La Roche Inc. | Process for making α,β-unsaturated carboxylic acids |
US5808088A (en) * | 1997-04-30 | 1998-09-15 | Roche Colorado Corporation | Preparation of mibefradil via an acetamide anion |
US5811556A (en) * | 1997-04-30 | 1998-09-22 | Roche Colorado Corporation | Preparation of mibefradil via a naphthalenylacetic acid |
US5811557A (en) * | 1997-04-30 | 1998-09-22 | Roche Colorado Corporation | Preparation of mibefradil via an acetonitrile anion |
BRPI0810399B8 (pt) | 2007-04-27 | 2021-05-25 | Actelion Pharmaceuticals Ltd | composto, composição farmacêutica que o contém e uso do mesmo |
WO2010046729A2 (en) * | 2008-10-23 | 2010-04-29 | Actelion Pharmaceuticals Ltd | Tetrahydronaphthalene compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5896045A (ja) * | 1981-11-30 | 1983-06-07 | Sumitomo Chem Co Ltd | 新規なジフエニルアルカノアミン誘導体およびその製造法 |
NZ213651A (en) * | 1984-10-11 | 1989-07-27 | Hoffmann La Roche | Tetrahydronapthalene derivatives and medicaments |
CA1319144C (en) * | 1986-11-14 | 1993-06-15 | Quirico Branca | Tetrahydronaphthalene derivatives |
-
1990
- 1990-03-05 CA CA002011461A patent/CA2011461A1/en not_active Abandoned
- 1990-03-09 EP EP90104562A patent/EP0388739A1/de not_active Withdrawn
- 1990-03-13 ZA ZA901926A patent/ZA901926B/xx unknown
- 1990-03-14 IL IL93750A patent/IL93750A0/xx unknown
- 1990-03-14 HU HU901556A patent/HUT58042A/hu unknown
- 1990-03-15 MC MC902118A patent/MC2105A1/xx unknown
- 1990-03-16 PH PH40216A patent/PH26903A/en unknown
- 1990-03-16 AU AU51403/90A patent/AU5140390A/en not_active Abandoned
- 1990-03-19 FI FI901363A patent/FI901363A0/fi not_active IP Right Cessation
- 1990-03-19 YU YU00534/90A patent/YU53490A/xx unknown
- 1990-03-19 PT PT93504A patent/PT93504A/pt not_active Application Discontinuation
- 1990-03-19 JP JP2067385A patent/JPH02279660A/ja active Pending
- 1990-03-19 KR KR1019900003627A patent/KR900014306A/ko not_active Application Discontinuation
- 1990-03-19 NO NO90901266A patent/NO901266L/no unknown
-
1991
- 1991-04-23 US US07/690,408 patent/US5120759A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO901266D0 (no) | 1990-03-19 |
HUT58042A (en) | 1992-01-28 |
AU5140390A (en) | 1990-11-15 |
EP0388739A1 (de) | 1990-09-26 |
MC2105A1 (fr) | 1991-03-11 |
HU901556D0 (en) | 1990-06-28 |
PH26903A (en) | 1992-12-03 |
US5120759A (en) | 1992-06-09 |
PT93504A (pt) | 1990-11-07 |
YU53490A (en) | 1991-10-31 |
JPH02279660A (ja) | 1990-11-15 |
IL93750A0 (en) | 1990-12-23 |
ZA901926B (en) | 1990-11-28 |
NO901266L (no) | 1990-09-21 |
CA2011461A1 (en) | 1990-09-20 |
KR900014306A (ko) | 1990-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI891631A0 (fi) | Bergborrningsanordning. | |
DE59008431D1 (de) | Triazolylsulfonamide. | |
FI896146A (fi) | Bettskivenhet. | |
FI891532A (fi) | Skaerningsanordning. | |
FI900398A0 (fi) | Underraettelseomformingsanordning. | |
DE69005107D1 (de) | Fusskreuz. | |
FI893687A (fi) | Ostpanna. | |
FI895972A0 (fi) | Vaexellaoda. | |
FI895945A (fi) | Stuvnings- och foerflyttningssystem. | |
FI895092A0 (fi) | Kopplingsdosa foer vattenarmatur. | |
ES1008798Y (es) | Bolsa-mochila. | |
ES1012497Y (es) | Alternador-depresor. | |
ES1011811Y (es) | Muneco-envase. | |
FI892766A0 (fi) | Ledskopa. | |
FI895134A0 (fi) | Foerpackning. | |
FI891088A (fi) | Undervattenskvarn. | |
FI891173A (fi) | Roekdetektorsystem. | |
FI891733A0 (fi) | Stroemskensystem. | |
FI891947A (fi) | Mattpapper. | |
FI892241A (fi) | Roerlucka. | |
FI892400A0 (fi) | Roermotstaond. | |
FI892403A (fi) | Kopplingsklaemma. | |
FI892438A (fi) | Golvkonstruktion foer vaotutrymmen. | |
FI892695A0 (fi) | Livsmedelsfoerpackning. | |
FI890970A0 (fi) | Avfallspress. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
MM | Patent lapsed |
Owner name: F. HOFFMANN - LA ROCHE AG |